Sun Pharmaceuticals Industries Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sun Pharmaceuticals Industries Ltd with three other
pharmaceutical manufacturers in Asia:
Kangmei Pharmaceutical Co Ltd
sales of 21.61 billion Chinese Renmimbi [US$3.14 billion]
of which 87%
(142.08 billion Indian Rupees [US$2.22 billion]
of which 100%
was Pharmaceuticals), and
Sumitomo Dainippon Pharma Co Ltd
based in Japan
(403.21 billion Japanese Yen [US$3.64 billion]
Sun Pharmaceuticals Industries Ltd reported sales of 282.70 billion Indian Rupees (US$4.41 billion)
March of 2016.
increase of 3.0%
versus 2015, when the company's sales were 274.33 billion Indian Rupees.
Sales at Sun Pharmaceuticals Industries Ltd have increased during each of the previous five years
(and since 2011, sales have increased a total of 394%).